COVID-19 Vaccination for Children 5 through 11 Years Old

Information for Jurisdictions, Healthcare Providers, Pharmacists, Schools, and Community Partners

CDC has expanded recommendations for booster shots to now include all adults ages 18 years and older who received a Pfizer-BioNTech or Moderna (mRNA) COVID-19 vaccine as part of their primary series. Get more information and read CDC’s media statement.

three illustrations of parents and guardians taking their children to receive COVID-19 vaccinations.

The federal government is committed to ensuring that children ages 5 through 11 years old have access to COVID-19 vaccines.  Scientists have conducted clinical trials with about 3,000 children, and the Food and Drug Administration (FDA) has determined that the Pfizer-BioNTech COVID-19 Vaccine has met the safety and efficacy standards for authorization in children ages 5 through 11 years old.  The safety of COVID-19 vaccines continues to be monitored.

This page shares up-to-date information and resources on how to help get children ages 5 through 11 years old vaccinated.

COVID-19 Vaccination Recommendations for Pediatric Populations

Children 5 years and older can get the Pfizer-BioNTech COVID-19 Vaccine. Children 5 through 11 years old will receive a separate vaccine formulation denoted with an orange cap of the Pfizer-BioNTech COVID-19 Vaccine, and will receive the vaccine with a smaller needle. An overview of the description of the differences in the adult/adolescent formulation and pediatric formulationpdf icon is available.

Children between the ages of 2 and 4 years old, other unvaccinated children 5 years or older and adults should continue to wear a mask in public spaces and around people they don’t live with.

Planning and Promoting COVID-19 Vaccination in Your Community
illustration of checklists

Pediatric COVID-19 Operational Planning Guidepdf icon

This guide outlines key aspects of a COVID-19 vaccination program for children 5 through 11 years old and was designed to inform jurisdictional planning under the assumption of FDA authorization and CDC recommendations of at least one COVID-19 vaccine product for children of this age. An overview of the description of the differences in the adult/adolescent formulation and pediatric formulationpdf icon is available.

Clinical Training and Education
Page last reviewed: November 18, 2021